A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia
出版年份 2014 全文链接
标题
A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia
作者
关键词
-
出版物
Science Translational Medicine
Volume 6, Issue 252, Pages 252ra121-252ra121
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2014-09-04
DOI
10.1126/scitranslmed.3009073
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations
- (2015) Jonathan M. Gerber et al. Oncotarget
- Concise Review: Cancer Cells Escape from Oncogene Addiction: Understanding the Mechanisms Behind Treatment Failure for More Effective Targeting
- (2014) Francesca Pellicano et al. STEM CELLS
- Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib
- (2012) Ling Li et al. CANCER CELL
- Elf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2
- (2012) Rumela Chakrabarti et al. NATURE CELL BIOLOGY
- The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells
- (2012) Haojian Zhang et al. NATURE GENETICS
- HemaExplorer: a database of mRNA expression profiles in normal and malignant haematopoiesis
- (2012) Frederik Otzen Bagger et al. NUCLEIC ACIDS RESEARCH
- ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
- (2012) Maria Kalyuga et al. PLOS BIOLOGY
- Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
- (2011) A. Hamilton et al. BLOOD
- Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease
- (2011) J.-C. Chomel et al. BLOOD
- Nilotinib and MEK Inhibitors Induce Synthetic Lethality through Paradoxical Activation of RAF in Drug-Resistant Chronic Myeloid Leukemia
- (2011) Leisl M. Packer et al. CANCER CELL
- Forced expression of the histone demethylase Fbxl10 maintains self-renewing hematopoietic stem cells
- (2011) Takaaki Konuma et al. EXPERIMENTAL HEMATOLOGY
- BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance
- (2011) Hilmar Quentmeier et al. Journal of Hematology & Oncology
- The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem/progenitor cells
- (2011) F Pellicano et al. LEUKEMIA
- Comprehensive Predictive Biomarker Analysis for MEK Inhibitor GSK1120212
- (2011) J. Jing et al. MOLECULAR CANCER THERAPEUTICS
- A framework for oligonucleotide microarray preprocessing
- (2010) Benilton S. Carvalho et al. BIOINFORMATICS
- Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland
- (2010) Rosalba Escamilla-Hernandez et al. BMC MOLECULAR BIOLOGY
- Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate
- (2010) Bin Zhang et al. CANCER CELL
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
- (2010) Amie S. Corbin et al. JOURNAL OF CLINICAL INVESTIGATION
- BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
- (2010) Xin An et al. LEUKEMIA RESEARCH
- ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity
- (2010) J. Colicelli Science Signaling
- Contribution of BCRâABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells
- (2009) Takeru Nambu et al. CANCER SCIENCE
- Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer
- (2009) J Mullenders et al. ONCOGENE
- ERK2, but Not ERK1, Mediates Acquired and “De novo” Resistance to Imatinib Mesylate: Implication for CML Therapy
- (2009) Clara I. Aceves-Luquero et al. PLoS One
- Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapy
- (2008) D Bruennert et al. LEUKEMIA
- PKC regulates occludin phosphorylation and epithelial tight junction integrity
- (2008) T. Suzuki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started